Emalex Biosciences today announced that the U.S. Food and Drug Administration has authorized the company’s Expanded Access Program (EAP) for ecopipam, an investigational therapy in development for the ...
WideTrial is an integrated service and technology platform that delivers scalable, group-level Expanded Access programs (EAPs) that are easy to participate in and improve patient access to ...
One night in November 2018, I fell while crossing a street in Subic Bay, a U.S. naval logistics station in The Philippines. My face whacked the asphalt. Lying in the path of oncoming traffic, I couldn ...
Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in ...
Cognition Therapeutics, Inc. announced the initiation of an expanded access program (EAP) funded by an anonymous philanthropic donation from the family of a patient with dementia with Lewy bodies (DLB ...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the Savara Early Access ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Ocugen’s expanded access program for the treatment of retinitis pigmentosa with OCU400, ...
Lipella Pharmaceuticals Inc. announced that the FDA has approved an Expanded Access Program for LP-310, an oral rinse formulated to treat oral lichen planus (OLP), a debilitating condition affecting ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The new drug application for ADX-2191 for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback